Hanna Honkanen1, Sami Oikarinen2,3, Noora Nurminen2, Olli H Laitinen4,5, Heini Huhtala6, Jussi Lehtonen2, Tanja Ruokoranta4, Minna M Hankaniemi4,5, Valérie Lecouturier7, Jeffrey W Almond7, Sisko Tauriainen8, Olli Simell9,10, Jorma Ilonen11, Riitta Veijola12, Hanna Viskari2,13, Mikael Knip14,15,16,17, Heikki Hyöty2,3. 1. Department of Virology, University of Tampere, PL100, 33014, Tampereen yliopisto, Finland. hanna.honkanen@uta.fi. 2. Department of Virology, University of Tampere, PL100, 33014, Tampereen yliopisto, Finland. 3. Fimlab Laboratories, Pirkanmaa Hospital District, Tampere, Finland. 4. Vactech Ltd, Tampere, Finland. 5. BioMediTech, University of Tampere, Tampere, Finland. 6. School of Health Sciences, University of Tampere, Tampere, Finland. 7. Sanofi-Pasteur, Marcy L'Etoile, France. 8. Department of Virology, University of Turku, Turku, Finland. 9. Department of Pediatrics and Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland. 10. Department of Pediatrics and Adolescent Medicine, Turku University Hospital, Turku, Finland. 11. Immunogenetics Laboratory, University of Turku and Turku University Hospital, Turku, Finland. 12. Department of Pediatrics, PEDEGO Research Unit, Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland. 13. Department of Internal Medicine, Tampere University Hospital, Tampere, Finland. 14. Children's Hospital, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland. 15. Research Programs Unit, Diabetes and Obesity, University of Helsinki, Helsinki, Finland. 16. Department of Pediatrics, Tampere University Hospital, Tampere, Finland. 17. Folkhälsan Research Center, Helsinki, Finland.
Abstract
AIMS/HYPOTHESIS: This case-control study was nested in a prospective birth cohort to evaluate whether the presence of enteroviruses in stools was associated with the appearance of islet autoimmunity in the Type 1 Diabetes Prediction and Prevention study in Finland. METHODS: Altogether, 1673 longitudinal stool samples from 129 case children who turned positive for multiple islet autoantibodies and 3108 stool samples from 282 matched control children were screened for the presence of enterovirus RNA using RT-PCR. Viral genotype was detected by sequencing. RESULTS: Case children had more enterovirus infections than control children (0.8 vs 0.6 infections per child). Time-dependent analysis indicated that this excess of infections occurred more than 1 year before the first detection of islet autoantibodies (6.3 vs 2.1 infections per 10 follow-up years). No such difference was seen in infections occurring less than 1 year before islet autoantibody seroconversion or after seroconversion. The most frequent enterovirus types included coxsackievirus A4 (28% of genotyped viruses), coxsackievirus A2 (14%) and coxsackievirus A16 (11%). CONCLUSIONS/ INTERPRETATION: The results suggest that enterovirus infections diagnosed by detecting viral RNA in stools are associated with the development of islet autoimmunity with a time lag of several months.
AIMS/HYPOTHESIS: This case-control study was nested in a prospective birth cohort to evaluate whether the presence of enteroviruses in stools was associated with the appearance of islet autoimmunity in the Type 1 Diabetes Prediction and Prevention study in Finland. METHODS: Altogether, 1673 longitudinal stool samples from 129 case children who turned positive for multiple islet autoantibodies and 3108 stool samples from 282 matched control children were screened for the presence of enterovirus RNA using RT-PCR. Viral genotype was detected by sequencing. RESULTS: Case children had more enterovirus infections than control children (0.8 vs 0.6 infections per child). Time-dependent analysis indicated that this excess of infections occurred more than 1 year before the first detection of islet autoantibodies (6.3 vs 2.1 infections per 10 follow-up years). No such difference was seen in infections occurring less than 1 year before islet autoantibody seroconversion or after seroconversion. The most frequent enterovirus types included coxsackievirus A4 (28% of genotyped viruses), coxsackievirus A2 (14%) and coxsackievirus A16 (11%). CONCLUSIONS/ INTERPRETATION: The results suggest that enterovirus infections diagnosed by detecting viral RNA in stools are associated with the development of islet autoimmunity with a time lag of several months.
Entities:
Keywords:
Enterovirus; Genotyping; RT-PCR; Stool samples; Type 1 diabetes
Authors: Elisabet Witsø; Ondrej Cinek; German Tapia; Caroline A Brorsson; Lars C Stene; Håkon K Gjessing; Trond Rasmussen; Regine Bergholdt; Flemming M Pociot; Kjersti S Rønningen Journal: Viral Immunol Date: 2015-10-20 Impact factor: 2.257
Authors: J Lempainen; S Tauriainen; O Vaarala; M Mäkelä; H Honkanen; J Marttila; R Veijola; O Simell; H Hyöty; M Knip; J Ilonen Journal: Diabetes Metab Res Rev Date: 2012-02 Impact factor: 4.876
Authors: Kirsti Näntö-Salonen; Antti Kupila; Satu Simell; Heli Siljander; Tiina Salonsaari; Anne Hekkala; Sari Korhonen; Risto Erkkola; Jukka I Sipilä; Lotta Haavisto; Marja Siltala; Juhani Tuominen; Jari Hakalax; Heikki Hyöty; Jorma Ilonen; Riitta Veijola; Tuula Simell; Mikael Knip; Olli Simell Journal: Lancet Date: 2008-09-22 Impact factor: 79.321
Authors: Sami Oikarinen; Mika Martiskainen; Sisko Tauriainen; Heini Huhtala; Jorma Ilonen; Riitta Veijola; Olli Simell; Mikael Knip; Heikki Hyöty Journal: Diabetes Date: 2010-10-13 Impact factor: 9.461
Authors: Amir-Babak Sioofy-Khojine; Jussi Lehtonen; Noora Nurminen; Olli H Laitinen; Sami Oikarinen; Heini Huhtala; Outi Pakkanen; Tanja Ruokoranta; Minna M Hankaniemi; Jorma Toppari; Mari Vähä-Mäkilä; Jorma Ilonen; Riitta Veijola; Mikael Knip; Heikki Hyöty Journal: Diabetologia Date: 2018-02-05 Impact factor: 10.122
Authors: Joseph W Dean; Leeana D Peters; Christopher A Fuhrman; Howard R Seay; Amanda L Posgai; Scott E Stimpson; Maigan A Brusko; Daniel J Perry; Wen-I Yeh; Brittney N Newby; Michael J Haller; Andrew B Muir; Mark A Atkinson; Clayton E Mathews; Todd M Brusko Journal: J Autoimmun Date: 2020-02-06 Impact factor: 7.094
Authors: Hanna Viskari; Sami Oikarinen; Sanna Hoppu; Tytti Vuorinen; Heini Huhtala; Jorma Toppari; Riitta Veijola; Jorma Ilonen; Mikael Knip; Heikki Hyöty Journal: Diabetologia Date: 2017-09-02 Impact factor: 10.122